pyrazines has been researched along with tiletamine hydrochloride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kashige, N; Maruoka, H; Miake, F; Yamaguchi, T | 1 |
| Utsunomya, A | 1 |
| Bonavida, B; Huerta-Yepez, S; Jazirehi, AR; Martinez-Maza, O; Martinez-Paniagua, M; Umezawa, K; Vega, MI | 1 |
| Aranda, E; Benito, MJ; Córdoba, JJ; Córdoba, MG; Martín, A; Ruiz-Moyano, S | 1 |
| Anderson, KC; Bobb, K; Carrasco, RD; Cirstea, D; Fabre, C; Gorgun, G; Hideshima, T; Hu, Y; Kong, SY; Meshulam, J; Mimura, N; Minami, J; Ohguchi, H; Richardson, PG; Tai, YT; Zhang, J | 1 |
| Abdelazeem, AH; Amjad, MW; Bukhari, SNA; Qin, HL; Raja, MAG; Youssif, BGM; Zha, GF | 1 |
| Alharbi, KS; Alotaibi, BS; Alotaibi, MR; Alotaibi, NH; Alotaibi, NM; Alruwaili, NK; Alzarea, AI; Bukhari, SNA | 1 |
1 review(s) available for pyrazines and tiletamine hydrochloride
| Article | Year |
|---|---|
[Clinical and hematological characteristics of adult T-cell leukemia/lymphoma].
Topics: Benzamides; Boronic Acids; Bortezomib; Carrier State; Cyclohexanones; HIV Protease Inhibitors; Human T-lymphotropic virus 1; Humans; Infectious Disease Transmission, Vertical; Leukemia-Lymphoma, Adult T-Cell; NF-kappa B; Protease Inhibitors; Pyrazines; Ritonavir; Stem Cell Transplantation; Transplantation, Homologous | 2006 |
6 other study(ies) available for pyrazines and tiletamine hydrochloride
| Article | Year |
|---|---|
Synthesis of new dihydropyrazines with DNA strand-breakage activity.
Topics: Cyclization; Cyclohexanones; Diamines; DNA; DNA Damage; Drug Evaluation, Preclinical; Molecular Structure; Pyrazines | 2005 |
The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Cell Line, Tumor; Cyclohexanones; Drug Resistance, Neoplasm; Humans; Lymphoma, AIDS-Related; Lymphoma, B-Cell; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rituximab | 2008 |
Characterization by volatile compounds of microbial deep spoilage in Iberian dry-cured ham.
Topics: Animals; Colony Count, Microbial; Color; Cyclohexanones; Enterobacteriaceae; Ethanol; Fermentation; Food Contamination; Food, Preserved; Gas Chromatography-Mass Spectrometry; Gram-Positive Cocci; Humans; Meat; Pyrazines; Quality Control; Solid Phase Microextraction; Swine; Volatile Organic Compounds | 2010 |
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Line, Tumor; Cyclohexanones; Doxorubicin; Epoxy Compounds; Humans; Leukocytes, Mononuclear; Mice; Multiple Myeloma; NF-kappa B; Osteoclasts; Pyrazines; RANK Ligand; Signal Transduction; Transplantation, Heterologous | 2012 |
Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclohexanones; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Oximes; Pyrazines; Structure-Activity Relationship | 2017 |
Pharmacological appraisal of ligustrazine based cyclohexanone analogs as inhibitors of inflammatory markers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanones; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Inflammation; Lipoxygenase Inhibitors; Pyrazines; Structure-Activity Relationship | 2020 |